BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 599774)

  • 1. [Studies on the mode of the immunopotentiating action of BCG (Part 2) (author's transl)].
    Harada Y
    Kekkaku; 1977 Nov; 52(11):541-7. PubMed ID: 599774
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the mode of the immunopotentiating action of BCG (Part 1) (author's transl)].
    Harada Y
    Kekkaku; 1977 Oct; 52(10):515-22. PubMed ID: 340746
    [No Abstract]   [Full Text] [Related]  

  • 3. [The immunopotentiating action of BCG and its various effects on tumors (author's transl)].
    Yamada H
    Kekkaku; 1978 Jan; 53(1):11-23. PubMed ID: 633697
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effects of BCG, cyclophosphamide and X-radiation on reticuloendothelial system and immune responsiveness in mice (Part 2) (author's transl)].
    Harada S
    Kekkaku; 1978 Feb; 53(2):77-83. PubMed ID: 633704
    [No Abstract]   [Full Text] [Related]  

  • 5. [Macrophage activation by viable BCG in tumor-bearing mice and its relation with delayed hypersensitivity (author's transl)].
    Matsuo K
    Fukuoka Igaku Zasshi; 1979 Aug; 70(8):465-83. PubMed ID: 488891
    [No Abstract]   [Full Text] [Related]  

  • 6. [Induction of suppressor adherent cells by injecting heavy dose of live BCG. I. In vitro analysis of suppression of BCG cell wall induced delayed type hypersensitivity (author's transl)].
    Kato K
    Kekkaku; 1980 Sep; 55(9):401-6. PubMed ID: 7431724
    [No Abstract]   [Full Text] [Related]  

  • 7. [Delayed local reaction (DLR) after BCG vaccination in mice. II.--Correlations with the immune response (author's transl)].
    Lagrange PH; Hurtrel B
    Ann Immunol (Paris); 1978; 129 C(4):547-58. PubMed ID: 697320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparability of delayed hypersensitivity in various rodents. II. Jones-Mote type hypersensitivity in guinea-pigs immunized with sheep erythrocytes and its modification by cyclophosphamide or BCG pre-treatment.
    Nomoto K; Yoshida S; Himeno K
    Immunology; 1980 Sep; 41(1):83-90. PubMed ID: 7429556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Involvement of the macrophage-like cells induced by live BCG injection in the tuberculous sensitization (author's transl)].
    Kato K
    Kekkaku; 1980 Nov; 55(11):510-2. PubMed ID: 7463931
    [No Abstract]   [Full Text] [Related]  

  • 10. [A review on mechanism of anti-tumor action of BCG (author's transl)].
    Tokunaga T
    Kekkaku; 1980 Aug; 55(8):351-7. PubMed ID: 6999202
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunotherapy of neoplasms. Part I - Assumptions (author's transl)].
    Szmigiel Z; Skotnicki AB
    Przegl Lek; 1975; 32(5):460-5. PubMed ID: 50612
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effects of BCG, cyclophosphamide and X-radiation on reticuloendothelial system and immune responsiveness in mice (Part 1) (author's transl)].
    Harada S
    Kekkaku; 1978 Jan; 53(1):1-10. PubMed ID: 633696
    [No Abstract]   [Full Text] [Related]  

  • 13. [BCG-allergy. Immunological basis and antigen choice (author's transl)].
    Depelchin A
    Acta Tuberc Pneumol Belg; 1974; 64(5):397-412. PubMed ID: 4546123
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dynamic aspects of immunocompetent cells for delayed hypersensitivity. Relationship between macrophage migration inhibition phenomenon and delayed skin reaction (author's transl)].
    Kino T
    Kekkaku; 1974 May; 49(5):117-25. PubMed ID: 4605633
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationships among differentiated T-cell subpopulations. I. Dissociated development of tuberculin type hypersensitivity, Jones-Mote type hypersensitivity and activation of helper function.
    Ohmichi Y; Nomoto K; Yamada H; Takeya K
    Immunology; 1976 Jul; 31(1):101-10. PubMed ID: 800398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of culture conditions (oxygenation) on the residual virulence of Brazil-BCG and Glaxo-BCG vaccines in mice].
    Feitosa JG; Gontijo Filho PP
    An Microbiol (Rio J); 1982; 27():51-67. PubMed ID: 6765359
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intensity of the delayed hypersensitivity reaction in mice from lines genetically selected for "high" and "low" antibody production (author's transl)].
    Mouton D; Bouthillier Y; Oriol R; Decreusefond C; Stiffel C; Biozzi G
    Ann Immunol (Paris); 1974 Jun; 125 C(4):581-8. PubMed ID: 4548831
    [No Abstract]   [Full Text] [Related]  

  • 18. [In vivo and in vitro study of the effects by cyclophosphamide on tuberculin hypersensitivity (author's transl)].
    Ikezawa Z; Minemura Y; Nagai R
    Nihon Hifuka Gakkai Zasshi; 1978 Aug; 88(9):553-60. PubMed ID: 309015
    [No Abstract]   [Full Text] [Related]  

  • 19. Cellular regulation of lung granuloma formation and delayed- type hypersensitivity induced with BCG cell walls. Further evidence of involvement of cellular immunity in lung granuloma formation.
    Yamamoto K; Kato K; Kakinuma M; Brehmer W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Mar; 251(3):357-68. PubMed ID: 7043952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmania mexicana in C3H mice: BCG and levamisole treatment of established infections.
    Grimaldi GF; Moriearty PL; Hoff R
    Clin Exp Immunol; 1980 Aug; 41(2):237-42. PubMed ID: 7438553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.